These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4978723)

  • 1. Alteration of a learned response of the squirrel monkey by hallucinogens.
    Uyeno ET
    Int J Neuropharmacol; 1969 May; 8(3):245-53. PubMed ID: 4978723
    [No Abstract]   [Full Text] [Related]  

  • 2. Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for 'hallucinogens'.
    Koerner J; Appel JB
    Psychopharmacology (Berl); 1982; 76(2):130-5. PubMed ID: 6805022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychotomimetic drugs: biochemistry and pharmacology.
    Brimblecombe RW
    Adv Drug Res; 1973; 7():165-206. PubMed ID: 4613150
    [No Abstract]   [Full Text] [Related]  

  • 4. The possible role of tryptamine in brain function and its relationship to the actions of LSD-like hallucinogens.
    Martin WR; Sloan JW
    Mt Sinai J Med; 1974; 41(2):276-82. PubMed ID: 4544624
    [No Abstract]   [Full Text] [Related]  

  • 5. 6-hydroxylated N,N-dimethyltryptamines and hallucinogenic potency.
    Uyeno ET
    Proc West Pharmacol Soc; 1969; 12():118-23. PubMed ID: 4980529
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacological action spectra of hallucinogens].
    Waser PG
    Bull Schweiz Akad Med Wiss; 1971 Jun; 27(1):39-57. PubMed ID: 5141141
    [No Abstract]   [Full Text] [Related]  

  • 7. Serotonin accumulation after monoamine oxidase inhibition. Effects of decreased impulse flow and of some anti-depressants and hallucinogens.
    Meek JL; Fuxe K
    Biochem Pharmacol; 1971 Mar; 20(3):693-706. PubMed ID: 5150164
    [No Abstract]   [Full Text] [Related]  

  • 8. The pharmacology of hallucinogens.
    Brawley P; Duffield JC
    Pharmacol Rev; 1972 Mar; 24(1):31-66. PubMed ID: 4626282
    [No Abstract]   [Full Text] [Related]  

  • 9. Hallucinogenic drugs of the indolealkylamine type and central monoamine neurons.
    Andén NE; Corrodi H; Fuxe K
    J Pharmacol Exp Ther; 1971 Nov; 179(2):236-49. PubMed ID: 5133600
    [No Abstract]   [Full Text] [Related]  

  • 10. Hallucinogens as discriminative stimuli.
    Winter JC
    Fed Proc; 1974 Jul; 33(7):1825-32. PubMed ID: 4209212
    [No Abstract]   [Full Text] [Related]  

  • 11. Discriminative stimulus properties of hallucinogens and related designer drugs.
    Glennon RA
    NIDA Res Monogr; 1991; (116):25-44. PubMed ID: 1369672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Electrographic and behavioral effects of various hallucinogens in the free cat].
    Rougeul A; Verdeaux J; Letalle A
    Rev Neurol (Paris); 1969 Jun; 120(6):391-4. PubMed ID: 5379317
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacologic studies on the structure-activity relationship of hydroxyindole alkylamines.
    Cerletti A; Taeschler M; Weidmann H
    Adv Pharmacol (1962); 1968; 6(Pt B):233-46. PubMed ID: 5658327
    [No Abstract]   [Full Text] [Related]  

  • 14. Structure-activity studies on a 5-hydroxytryptamine receptor of Helix aspersa neurones.
    Walker RJ; Woodruff GN
    Br J Pharmacol; 1971 Oct; 43(2):415P-416P. PubMed ID: 5158207
    [No Abstract]   [Full Text] [Related]  

  • 15. Self-association and binding sites of some psychotomimetic tryptamine derivatives and related compounds: nuclear magnetic resonance investigations.
    Sapper H; Lohmann W
    Mol Pharmacol; 1976 Jul; 12(4):605-11. PubMed ID: 958209
    [No Abstract]   [Full Text] [Related]  

  • 16. Relative potency of amphetamine derivatives and N,N-dimethyltryptamines.
    Uyeno ET
    Psychopharmacologia; 1971; 19(4):381-7. PubMed ID: 5565249
    [No Abstract]   [Full Text] [Related]  

  • 17. Lysergic acid diethylamide (LSD) as a discriminative cue: drugs with similar stimulus properties.
    Schechter MD; Rosecrans JA
    Psychopharmacologia; 1972; 26(3):313-6. PubMed ID: 5073050
    [No Abstract]   [Full Text] [Related]  

  • 18. 2,5-dimethoxy-4-methyl-amphetamine (STP): a new hallucinogenic drug.
    Snyder SH; Faillace L; Hollister L
    Science; 1967 Nov; 158(3801):669-70. PubMed ID: 4860952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Speculations on the mechanism of action of hallucinogenic indolealkylamines.
    Glennon RA; Rosecrans JA
    Neurosci Biobehav Rev; 1981; 5(2):197-207. PubMed ID: 7022271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of hallucinogens at the clinical level.
    Wyatt RJ; Cannon EH; Stoff DM; Gillin JC
    Ann N Y Acad Sci; 1976; 281():456-86. PubMed ID: 828469
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.